NCT00000282CompletedPhase 2
Pemoline for Cocaine Abuse
Conditions
Drugs
Trial Snapshot
- Phase
- Phase 2
- Status
- Completed
- Sponsor
- Yale University
- Locations
- 1
- Primary Endpoint
- Retention
Study Overview
Brief Summary
The purpose of this study is to evaluate the treatment of pemoline for cocaine abuse.
Study Design
- Study Type
- Interventional
- Primary Purpose
- Treatment
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Please contact site for information.
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Retention
Side effects
Drug use
Secondary Outcomes
No secondary outcomes reported
Investigators
Study Sites (1)
Loading locations...
Similar Trials
Withdrawn
Phase 2
Pemoline in the Treatment of Stimulant Dependence - 5Cocaine-Related DisordersNCT00000340National Institute on Drug Abuse (NIDA)
Completed
Phase 2
Pergolide Treatment for Substance Abusers - 4Cocaine-Related DisordersSubstance-Related DisordersNCT00000269National Institute on Drug Abuse (NIDA)
Completed
Phase 2
Selegiline in Treatment of Cocaine Dependence - 2Cocaine-Related DisordersNCT00000188University of Pennsylvania50
Completed
Phase 2
New Approaches to Cocaine Abuse Medications (A) - 6Cocaine-Related DisordersSubstance-Related DisordersNCT00000271New York State Psychiatric Institute111
Completed
Phase 3
Dose Response Trial of Pergolide for Cocaine Dependence - 1Cocaine-Related DisordersNCT00000248Medical University of South Carolina